IUHSA
Itau Unibanco Holding S.A. Portfolio holdings
AUM
$2.63B
1-Year Return
21.65%
This Quarter Return
-3.58%
1 Year Return
+21.65%
3 Year Return
+79.74%
5 Year Return
+135.75%
10 Year Return
–
AUM
$2.25B
AUM Growth
+$110M
(+5.1%)
Cap. Flow
+$121M
Cap. Flow
% of AUM
5.39%
Top 10 Holdings %
Top 10 Hldgs %
49.7%
Holding
571
New
74
Increased
158
Reduced
177
Closed
108
Top Buys
| 1 |
iShares US Treasury Bond ETF
GOVT
|
+$98.2M |
| 2 |
iShares 10-20 Year Treasury Bond ETF
TLH
|
+$97.6M |
| 3 |
iShares Biotechnology ETF
IBB
|
+$48.2M |
| 4 |
Energy Select Sector SPDR Fund
XLE
|
+$26.1M |
| 5 |
Keurig Dr Pepper
KDP
|
+$25.9M |
Top Sells
| 1 |
Petrobras
PBR
|
+$60.5M |
| 2 |
Fomento Económico Mexicano
FMX
|
+$37.2M |
| 3 |
TSMC
TSM
|
+$29.4M |
| 4 |
Credicorp
BAP
|
+$28M |
| 5 |
Chevron
CVX
|
+$22.4M |
Sector Composition
| 1 | Financials | 10.87% |
| 2 | Materials | 10.31% |
| 3 | Technology | 9.2% |
| 4 | Consumer Staples | 8.8% |
| 5 | Energy | 8.46% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
IMGN
376
DELISTED
Immunogen Inc
IMGN
| $16.3K | ﹤0.01% |
1,028
| – | – |
|
377
PTC
PTC
$24.4B
| $15.7K | ﹤0.01% |
111
-64
| -37% | -$9.07K |
|
378
Adeia
ADEA
$1.68B
| $15.6K | ﹤0.01% |
1,584
+389
| +33% | +$3.84K |
|
|
TSP
379
DELISTED
TuSimple Holdings Inc. Class A Common Stock
TSP
| $15.6K | ﹤0.01% |
9,983
+2,454
| +33% | +$3.83K |
|
380
Bruker
BRKR
$4.73B
| $15.4K | ﹤0.01% |
247
| – | – |
|
381
Allogene Therapeutics
ALLO
$253M
| $14.9K | ﹤0.01% |
4,699
+1,155
| +33% | +$3.66K |
|
382
Avidity Biosciences
RNA
$6B
| $14.8K | ﹤0.01% |
2,314
+569
| +33% | +$3.63K |
|
383
Planet Labs
PL
$2.74B
| $14.7K | ﹤0.01% |
5,635
+1,385
| +33% | +$3.6K |
|
384
Butterfly Network
BFLY
$398M
| $14.5K | ﹤0.01% |
12,253
+3,013
| +33% | +$3.56K |
|
385
Starbucks
SBUX
$95.3B
| $14.4K | ﹤0.01% |
158
-1
| -0.6% | -$91 |
|
386
Teladoc Health
TDOC
$1.38B
| $14.3K | ﹤0.01% |
769
| – | – |
|
387
Repligen
RGEN
$6.68B
| $14K | ﹤0.01% |
88
-402
| -82% | -$63.9K |
|
388
Charles River Laboratories
CRL
$7.75B
| $13.9K | ﹤0.01% |
71
-763
| -91% | -$150K |
|
389
Wolfspeed
WOLF
$285M
| $13.9K | ﹤0.01% |
365
| – | – |
|
390
Hyliion Holdings
HYLN
$282M
| $13K | ﹤0.01% |
11,044
+2,715
| +33% | +$3.2K |
|
391
Exelixis
EXEL
$10.3B
| $13K | ﹤0.01% |
596
| – | – |
|
392
Boston Properties
BXP
$11.5B
| $12.8K | ﹤0.01% |
215
| – | – |
|
393
Workhorse Group
WKHS
$18.3M
| $12.7K | ﹤0.01% |
123
+30
| +32% | +$3.11K |
|
394
Vuzix
VUZI
$178M
| $12.7K | ﹤0.01% |
3,502
+861
| +33% | +$3.13K |
|
395
Virgin Galactic
SPCE
$183M
| $11.9K | ﹤0.01% |
330
+81
| +33% | +$2.92K |
|
396
Owens Corning
OC
$12.5B
| $11.9K | ﹤0.01% |
+87
| New | +$11.9K |
|
|
ME
397
DELISTED
23andMe Holding Co. Class A Common Stock
ME
| $11.8K | ﹤0.01% |
606
+149
| +33% | +$2.91K |
|
398
Ultragenyx Pharmaceutical
RARE
$3.04B
| $11.8K | ﹤0.01% |
330
| – | – |
|
399
TopBuild
BLD
$11.8B
| $11.6K | ﹤0.01% |
46
| – | – |
|
400
Carlisle Companies
CSL
$16.3B
| $11.4K | ﹤0.01% |
44
| – | – |
|